Abstract
Troponin T (TnT) elevation above the 99th percentile upper reference limit (URL) is considered diagnostic of acute myocardial infarction (MI). Non-specific increases of TnT are frequent in acute stroke patients. However, in these patients, correct diagnosis of MI is crucial because the antithrombotic medications used to treat acute MI might be harmful and produce intracranial bleeding. In this study, we aimed to associate enhanced TnT levels defined by different cutoff values with occurrence of culprit lesion coronary artery disease (CAD) as well as 1-year major adverse cerebral and cardiovascular events (MACCEs). In this cohort study, we investigated 84 consecutive patients with acute ischemic stroke and concomitant MI. TnT levels were measured using a fourth-generation TnT assay. The incidence of culprit lesion CAD was determined by coronary angiography. MACCEs were recorded during 1-year follow-up. Culprit lesion CAD occurred in 55 % of patients, and 1-year MACCE in 37 %. TnT levels above the manufacturers’ provided 99th URL (TnT > 0.01) were not associated with culprit lesion CAD (relative risk [RR], 1.3; 95 % confidence interval [CI] 0.96–1.8; P = 0.09). Slightly increased cutoff level (TnT > 0.03) increased specificity and was associated with culprit lesion CAD without decreasing sensitivity (RR, 1.5; 95 % CI 1.1–2.2; P = 0.021) and 1-year MACCE (RR, 1.7; 95 % CI 1.3–2.3; P < 0.001). Slightly increasement of the TnT cutoff level predicted MACCEs and is superior in prediction of culprit lesion CAD in stroke patients without being less sensitive. This finding has to be confirmed in large-scale clinical trials.
Similar content being viewed by others
Abbreviations
- CAD:
-
Coronary artery disease
- MACCE:
-
Major adverse cerebral and cardiovascular event
- MI:
-
Myocardial infarction
- TIA:
-
Transient ischemic attack
- TnT:
-
Troponin T
References
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60:1581–98.
Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation. 2007;115:e356–75.
Scheitz JF, Nolte CH, Laufs U, Endres M. Application and interpretation of high-sensitivity cardiac troponin assays in patients with acute ischemic stroke. Stroke. 2015;46:1132–40.
Prosser J, MacGregor L, Lees KR, Diener HC, Hacke W, Davis S. Predictors of early cardiac morbidity and mortality after ischemic stroke. Stroke. 2007;38:2295–302.
Kumar S, Selim MH, Caplan LR. Medical complications after stroke. Lancet Neurol. 2010;9:105–18.
Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35:2541–619.
Mullins ME, Lev MH, Schellingerhout D, Gonzalez RG, Schaefer PW. Intracranial hemorrhage complicating acute stroke: how common is hemorrhagic stroke on initial head CT scan and how often is initial clinical diagnosis of acute stroke eventually confirmed? AJNR Am J Neuroradiol. 2005;26:2207–12.
Dg A. Practical statistics for medical research. London: Chapman and Hall; 1991.
Samuels MA. ‘Voodoo’ death revisited: the modern lessons of neurocardiology. Cleve Clin J Med. 2007;74 Suppl 1:S8–16.
Barber M, Morton JJ, Macfarlane PW, Barlow N, Roditi G, Stott DJ. Elevated troponin levels are associated with sympathoadrenal activation in acute ischaemic stroke. Cerebrovasc Dis. 2007;23:260–6.
Baroldi G. Different types of myocardial necrosis in coronary heart disease: a pathophysiologic review of their functional significance. Am Heart J. 1975;89:742–52.
Newby LK, Jesse RL, Babb JD, Christenson RH, De Fer TM, Diamond GA, et al. ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2012;60:2427–63.
Lyckman AW, Horng S, Leamey CA, Tropea D, Watakabe A, Van Wart A, et al. Gene expression patterns in visual cortex during the critical period: synaptic stabilization and reversal by visual deprivation. Proc Natl Acad Sci U S A. 2008;105:9409–14.
Chen C, Liu JB, Bian ZP, Xu JD, Wu HF, Gu CR, et al. Cardiac troponin I is abnormally expressed in non-small cell lung cancer tissues and human cancer cells. Int J Clin Exp Pathol. 2014;7:1314–24.
Song HS, Back JH, Jin DK, Chung PW, Moon HS, Suh BC, et al. Cardiac troponin T elevation after stroke: relationships between elevated serum troponin T, stroke location, and prognosis. J Clin Neurol. 2008;4:75–83.
Florkowski CM. Sensitivity, specificity, receiver-operating characteristic (ROC) curves and likelihood ratios: communicating the performance of diagnostic tests. Clin Biochem Rev / Australian Assoc Clin Biochem. 2008;29 Suppl 1:S83–7.
Maoz A, Rosenberg S, Leker RR. Increased High-Sensitivity Troponin-T Levels Are Associated with Mortality After Ischemic Stroke. J Mol Neurosci. 2015;57(2):160–5.
Faiz KW, Thommessen B, Einvik G, Omland T, Ronning OM. Prognostic value of high-sensitivity cardiac troponin T in acute ischemic stroke. J Stroke Cerebrovasc Dis : Off J Nat Stroke Assoc. 2014;23:241–8.
Kerr G, Ray G, Wu O, Stott DJ, Langhorne P. Elevated troponin after stroke: a systematic review. Cerebrovasc Dis. 2009;28:220–6.
Scheitz JF, Endres M, Mochmann HC, Audebert HJ, Nolte CH. Frequency, determinants and outcome of elevated troponin in acute ischemic stroke patients. Int J Cardiol. 2012;157:239–42.
Melki D, Lind S, Agewall S, Jernberg T. Diagnostic value of high sensitive troponin T in chest pain patients with no persistent ST-elevations. Scand Cardiovasc J : SCJ. 2011;45:198–204.
Authors’ contributions
T.Z. and A.P. designed the study, analyzed and interpreted data, and wrote the manuscript. U.K., D.L., L.G., R.W., F.B., and M.G. collected data and revised the manuscript. S.J. and M.K. supervised the study and revised the manuscript.
Financial support
Dr. Polzin is funded by the Forschungskommission of the Medical Faculty of the Heinrich Heine University (No. 16-2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
None
Funding source
Dr. Polzin is funded by the Forschungskommission of the Medical Faculty of the Heinrich Heine University (No. 16-2014).
Ethics Committee Approval
The study conformed to the Declaration of Helsinki and was approved by the University of Düsseldorf Ethics Committee.
Rights and permissions
About this article
Cite this article
Zeus, T., Ketterer, U., Leuf, D. et al. Troponin T in Prediction of Culprit Lesion Coronary Artery Disease and 1-Year Major Adverse Cerebral and Cardiovascular Events in Patients with Acute Stroke. Transl. Stroke Res. 7, 180–185 (2016). https://doi.org/10.1007/s12975-016-0457-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12975-016-0457-7